White Paper
Multi-Omics in the Cloud
How DNAnexus & AWS Accelerate Scientific Discoveries Featured Partner: 
Today’s genomics landscape is rapidly evolving with the accelerated adoption of multi-omics by biopharma organizations, clinical diagnostics companies, and healthcare systems.
NGS data analysis management systems are the backbone of your dry lab, providing vital functionality for day-to-day workings of your business delivery.
While modern-day drug discovery lacks the drama of Greek mythology, we are still faced with the odyssey of how to deliver on the promise of genomics-based precision medicine.
The promise of precision medicine and better patient outcomes is here, through the utilization and application of genomic data in biomarker discovery and clinical research.
Learn why the FDA, top pharmaceutical companies, global diagnostic test providers, genome centers and sequencing service providers have trusted DNAnexus to support their global genomics programs.
You’ve jumped ahead of the curve, leveraging next-generation sequencing (NGS) to advance precision medicine for better patient care, and you are now experiencing an explosion of demand.
DNAnexus Platform enables researchers and clinicians to focus on their genomic analyses while complying with regulations, laws and industry expectations for security and privacy.
The underlying infrastructure that DNAnexus provides, allows us to focus on our core competencies of R&D and patient care.
Experts from RStudio, UK Biobank and DNAnexus will walk attendees through using RStudio Workbench to analyze the extensive UK Biobank dataset, available to all UK Biobank researchers free of charge until August 31. This webinar will provide an overview on how to create notebooks, dashboards and incorporate Shiny apps all in the cloud on the Research Analysis Platform.
Speakers:
Aleks Stempor, PhD, Bioinformatician @UK Biobank
Phil Bowsher, Director of Healthcare and Life Sciences @RStudio
Anastazie Sedlakova, PhD, Sr. Community Engagement Scientist @DNAnexus Inc
